Prediction of Ovarian Follicular Dominance by MRI Phenotyping of Hormonally Induced Vascular Remodeling.

MRI angiogenesis bi-modal imaging blood volume corpus luteum dominant follicle ovary permeability

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2021
Historique:
received: 19 05 2021
accepted: 26 07 2021
entrez: 7 9 2021
pubmed: 8 9 2021
medline: 8 9 2021
Statut: epublish

Résumé

In the mammalian female, only a small subset of ovarian follicles, known as the dominant follicles (DFs), are selected for ovulation in each reproductive cycle, while the majority of the follicles and their resident oocytes are destined for elimination. This study aimed at characterizing early changes in blood vessel properties upon the establishment of dominance in the mouse ovary and application of this vascular phenotype for prediction of the follicles destined to ovulate. Sexually immature mice, hormonally treated for induction of ovulation, were imaged at three different stages by dynamic contrast-enhanced (DCE) MRI: prior to hormonal administration, at the time of DF selection, and upon formation of the corpus luteum (CL). Macromolecular biotin-bovine serum albumin conjugated with gadolinium-diethylenetriaminepentaacetic acid (b-BSA-GdDTPA) was intravenously injected, and the dynamics of its extravasation from permeable vessels as well as its accumulation in the antral cavity of the ovarian follicles was followed by consecutive T

Identifiants

pubmed: 34490300
doi: 10.3389/fmed.2021.711810
pmc: PMC8417579
doi:

Types de publication

Journal Article

Langues

eng

Pagination

711810

Informations de copyright

Copyright © 2021 Fellus-Alyagor, Biton, Dafni, Bochner, Rotkopf, Dekel and Neeman.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biol Reprod. 2003 Jun;68(6):2055-64
pubmed: 12606340
Biol Reprod. 2009 Nov;81(5):966-77
pubmed: 19605787
J Reprod Fertil. 1976 Sep;48(1):109-18
pubmed: 966215
Fertil Steril. 2013 Mar 1;99(3):903-9
pubmed: 23219013
Endocr Rev. 2000 Apr;21(2):200-14
pubmed: 10782364
Br J Cancer. 2020 Jul;123(2):216-225
pubmed: 32390007
NMR Biomed. 2002 Apr;15(2):120-31
pubmed: 11870908
Am J Pathol. 2001 Nov;159(5):1661-70
pubmed: 11696427
Mol Endocrinol. 2014 Jul;28(7):1039-54
pubmed: 24825398
Reproduction. 2011 Jun;141(6):821-31
pubmed: 21393340
J Cyclic Nucleotide Res. 1977 Jun;3(3):163-76
pubmed: 198442
Reproduction. 2009 Dec;138(6):869-81
pubmed: 19786399
Biol Reprod. 2016 Jan;94(1):14
pubmed: 26490838
Hum Reprod Update. 2014 Jan-Feb;20(1):29-39
pubmed: 24097804
Magn Reson Med. 1995 Aug;34(2):213-8
pubmed: 7476080
Hum Reprod. 2011 Jul;26(7):1616-24
pubmed: 21505041
Biol Reprod. 1995 Jun;52(6):1426-35
pubmed: 7543299
J Clin Invest. 2003 Sep;112(5):659-69
pubmed: 12952915
Biol Reprod. 2004 Aug;71(2):502-7
pubmed: 15070831
Sci Rep. 2015 Jul 24;5:12446
pubmed: 26207832
Hum Reprod. 2006 Dec;21(12):3096-102
pubmed: 16923746
Biol Reprod. 2003 May;68(5):1736-41
pubmed: 12606430
Microvasc Res. 2001 Jul;62(1):15-25
pubmed: 11421657
Neoplasia. 2005 Mar;7(3):224-33
pubmed: 15799822
Cardiovasc Res. 2010 Jul 15;87(2):262-71
pubmed: 20400620
Magn Reson Med. 1999 Jan;41(1):113-23
pubmed: 10025618
Endocr Rev. 2014 Oct;35(5):747-94
pubmed: 25051334
Fertil Steril. 2014 Feb;101(2):536-44
pubmed: 24188879
Physiologist. 1981 Feb;24(1):3-7
pubmed: 7012863
Fertil Steril. 1973 Jun;24(6):429-34
pubmed: 4122802
J Am Chem Soc. 2018 Dec 19;140(50):17456-17464
pubmed: 30484648
Mol Hum Reprod. 2007 Oct;13(10):729-36
pubmed: 17804434
Results Probl Cell Differ. 2016;58:167-90
pubmed: 27300179
J Clin Endocrinol Metab. 2001 Jul;86(7):3377-86
pubmed: 11443214
Reprod Biol Endocrinol. 2006 Apr 12;4:18
pubmed: 16611363
Fertil Steril. 2016 Jun;105(6):1452-3
pubmed: 26921622
Vet J. 2009 Sep;181(3):232-40
pubmed: 18693121
J Clin Invest. 2010 Apr;120(4):963-72
pubmed: 20364094
Nat Med. 1998 Mar;4(3):336-40
pubmed: 9500609
J Reprod Fertil. 1980 Mar;58(2):295-300
pubmed: 7191892
J Clin Invest. 2013 Aug;123(8):3472-87
pubmed: 23867505
J Reprod Dev. 2007 Feb;53(1):39-44
pubmed: 17332698
Hum Reprod. 2011 Jul;26(7):1768-74
pubmed: 21558332
Anim Reprod Sci. 2013 May;138(3-4):188-93
pubmed: 23582607
J Reprod Fertil. 1992 Jul;95(2):539-50
pubmed: 1518008
Angiogenesis. 2005;8(2):169-82
pubmed: 16211363
Reprod Biol. 2014 Apr;14(2):103-9
pubmed: 24856468
Anim Reprod Sci. 2014 Jan 10;144(1-2):30-7
pubmed: 24290565
Magn Reson Med. 2004 Oct;52(4):741-50
pubmed: 15389965
Endocrinology. 1981 Aug;109(2):356-62
pubmed: 6265188
Biol Reprod. 2002 Oct;67(4):1305-12
pubmed: 12297549
J Magn Reson Imaging. 1999 Jun;9(6):794-803
pubmed: 10373027
Angiogenesis. 2008;11(2):109-19
pubmed: 18293091
Histochem Cell Biol. 2006 Nov;126(5):583-92
pubmed: 16758163
J Clin Endocrinol Metab. 2005 Feb;90(2):1114-22
pubmed: 15562010
Anat Histol Embryol. 2000 Oct;29(5):257-66
pubmed: 11103513
J Reprod Dev. 2005 Feb;51(1):161-8
pubmed: 15750308
Hum Reprod. 2006 Jun;21(6):1368-79
pubmed: 16459346
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10185-90
pubmed: 18632559

Auteurs

Liat Fellus-Alyagor (L)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Inbal E Biton (IE)

Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.

Hagit Dafni (H)

Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.

Filip Bochner (F)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Ron Rotkopf (R)

Department of Life Science Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Nava Dekel (N)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Michal Neeman (M)

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Classifications MeSH